Related Experiment Video
Updated: Jul 31, 2025

06:27
Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
Published on: May 2, 2025
231
An Implantable Wireless System for Remote Hemodynamic Monitoring of Heart Failure Patients
Summary
This study introduces an implantable wireless system for continuous hemodynamic monitoring. The device enables simultaneous measurement of pulmonary arterial pressure and artery diameter, offering a new tool for remote patient care.
Area of Science:
- Biomedical Engineering
- Medical Devices
- Implantable Sensors
Background:
- Remote hemodynamic monitoring is crucial for managing cardiovascular diseases.
- Existing methods often lack continuous, simultaneous measurement capabilities.
- Minimally invasive, implantable solutions are needed for long-term patient management.
Purpose of the Study:
- To develop and characterize an implantable wireless system for continuous, simultaneous monitoring of pulmonary arterial pressure (PAP) and artery cross-sectional area (CSA).
- To evaluate the system's performance in terms of resolution, energy efficiency, and data transfer capabilities.
Main Methods:
- An implantable device integrating a piezoresistive pressure sensor, ASIC, piezoelectric ultrasound transducer, and nitinol anchoring loop was designed.
- Energy-efficient techniques including duty-cycling and spinning excitation were employed for pressure monitoring.
- Artery diameter was measured using the inductive properties of the anchoring loop.
- Wireless power and data transfer were achieved using a single piezoelectric transducer with ASK modulation.
Main Results:
- The system achieved 0.44 mmHg pressure resolution and 0.24 mm diameter resolution.
- It demonstrated high energy efficiency with 1.1 nJ conversion energy for pressure monitoring.
- Ultrasound link efficiency was 1.8% with uplink data rates up to 50 kbps.
- Accurate detection of pressure peaks in an in-vitro arterial flow model was confirmed.
Conclusions:
- The developed implantable wireless system offers a promising solution for continuous, remote hemodynamic monitoring.
- The system provides high-resolution, simultaneous measurements of PAP and artery CSA.
- Its performance in emulated physiological conditions suggests potential for clinical applications in cardiovascular disease management.
More Related Videos
Related Concept Videos
Pulse rhythm
860
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
860
Holter Monitor: 24-Hour Monitoring
75
Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
75
Heart Failure VI: Adjunct Therapies
19
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
19

